🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to determine the safety and efficacy o...
Status
Unknown
Location
The Affiliated People's Hospital of Ningbo University
Start Date
2021-09-16
Trial ID
NCT05528887
Treatments Being Tested
Phase I study to establish safety and feasibility of intravenously administ...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2014-06
Trial ID
NCT02159716
Treatments Being Tested
The purpose of this study is to collect data on the safety and potential ef...
Status
Completed
Location
Roger Williams Medical Center
Start Date
2011-06
Trial ID
NCT01373047
Treatments Being Tested
RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Status
Unknown
Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
Start Date
2015-10
Trial ID
NCT02580747
Treatments Being Tested
This research study is being carried out to study a new way to possibly tre...
Status
Active Not Recruiting
Location
University of Pennsylvania
Start Date
2019-07-31
Trial ID
NCT03617198
Treatments Being Tested
The purpose of this study is to determine whether autologous T cells bearin...
Status
Unknown
Location
PersonGen Biomedicine (Suzhou) Co., Ltd.
Start Date
2015-10
Trial ID
NCT02587689
Treatments Being Tested
The objective of this study is to determine the performance characteristics...
Status
Not Yet Recruiting
Location
The Children's Hospital of Philadelphia
Start Date
2027-01-01
Trial ID
NCT07023380
Treatments Being Tested
This is a phase I single center dose escalation study with an extension at ...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-11-08
Trial ID
NCT01634217
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
This clinical study is to investigate the safety and tolerability of CAR mo...
Status
Terminated
Location
Shanghai Zhongshan Hospital
Start Date
2019-05-16
Trial ID
NCT03960060
Treatments Being Tested